6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile is a biologically active compound, which is utilized for research in the fields of chemistry and life sciences.
Cas No. 1314134-92-3
Customer service consultation
Pack Size
Price
USA Stock
Global Stock
Quantity
1 mg
$48
In Stock
In Stock
5 mg
$113
In Stock
In Stock
10 mg
$165
In Stock
In Stock
25 mg
$248
In Stock
In Stock
50 mg
$348
In Stock
In Stock
100 mg
$475
In Stock
In Stock
1 mL x 10 mM (in DMSO)
$123
In Stock
In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile is a biologically active compound, which is utilized for research in the fields of chemistry and life sciences.
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (131.72 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg
5mg
10mg
50mg
1 mM
2.3950 mL
11.9749 mL
23.9498 mL
119.7490 mL
5 mM
0.4790 mL
2.3950 mL
4.7900 mL
23.9498 mL
10 mM
0.2395 mL
1.1975 mL
2.3950 mL
11.9749 mL
20 mM
0.1197 mL
0.5987 mL
1.1975 mL
5.9875 mL
50 mM
0.0479 mL
0.2395 mL
0.4790 mL
2.3950 mL
100 mM
0.0239 mL
0.1197 mL
0.2395 mL
1.1975 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.
Calculator
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 10%DMSO+ 40%PEG300+ 5%Tween 80+ 45%Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μLDMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μLPEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μLTween 80 and mix well until fully clarified.
3) Add 450 μLSaline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile chemical structure | 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile formula | 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile molecular weight